APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility

Rheumatology

Volumn 46, Issue 8, 2007, Pages 1274-1276

  Lee, Y H ^a   Ota, F ^b   Kim Howard, X ^b   Kaufman, K M ^b   Nath, Swapan K ^b  

^a Korea University Ansan Hospital   (South Korea)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

APRIL; Polymorphisms; Systemic lupus erythematosus

Indexed keywords

APRIL PROTEIN;

AFRICAN AMERICAN; ALLELE; ARTICLE; CHI SQUARE TEST; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC GROUP; ETHNICITY; EUROPEAN AMERICAN; GENETIC ASSOCIATION; GENOTYPE; HISPANIC; HUMAN; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; REGISTER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OKLAHOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 34547852178     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem093     Document Type: Article

References (13)

1. Hahne M, Kataoka T, Schroter M et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998;188:1185-90.
2. Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000;10:785-8.
3. Stohl W, Metyas S, Tan SM et al. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2004;63:1096-103.
4. Thompson JS, Schneider P, Kalled SL et al. BAFF binds to the tumor necrosis factor receptor-like molecule B-cell maturation antigen and is important for maintaining the peripheral B-cell population. J Exp Med 2000;192:129-35.
5. Mackay F, Woodcock SA, Lawton P et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999;190:1697-710.
6. Stein JV, Lopez-Fraga M, Elustondo FA et al. APRIL modulates B and T-cell immunity. J Clin Invest 2002;109:1587-98.
7. Rennert P, Schneider P, Cachero TG et al. A soluble form of B-cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med 2000;192:1677-84.
8. Nath SK, Kelly JA, Namjou B et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001;69:1401-6.
9. Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004;74:188-91.
10. Koyama T, Tsukamoto H, Masumoto K et al. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology 2003;42:980-5.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
12. Kaufman KM, Kelly JA, Herring BJ et al. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006;54:2533-40.
13. Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000;67:947-59.